Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2022 | Session highlights: integrating cellular therapy in myeloma

Krina Patel, MD, Msc, The University of Texas MD Anderson Cancer Center, Houston, TX, gives an overview of her presentation at the 2022 IMS meeting, which covered several topics, including how to optimize treatment approaches and patient access to CAR-T therapy, patient eligibility for CAR-T, and issues with manufacturing processes. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.